biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > $200k non-brokered raise

<< Previous

Bullboard Posts

Next >>

Comment by KayakerBCon Feb 19, 2022 9:35am

100 Views

Post# 34444684

RE:RE:RE:RE:RE:RE:$200k non-brokered raise

aacchhhhh,,,,Stockhouse is a better platform. All perspectives should be welcomed.

I don't participate here because of the clowns and whiners and the endless fights. How many others out there are the same?

You're pretty chill about it but not all of us eat marijuana pancakes for breakfast.

<< Previous

Bullboard Posts

Next >>

Pro Women’s Hockey League comes to NHL 25 in December